Articles
Volume 2 Supplement 1
Second International Symposium on the Molecular Biology of Breast Cancer
- Meeting abstracts
- from Second International Symposium on the Molecular Biology of Breast Cancer
- Lillehammer, Norway
- 12-16 March 2000
|
Meeting abstract
N Arnold, E Gross, H Peper, K Bandick, W Jonat, M Kiechle Breast Cancer Res 2000, 2(Suppl 1):P1.01 (12 March 2000) |
|
Meeting abstract
J Hartikainen, V Kataja, A Mannermaa Breast Cancer Res 2000, 2(Suppl 1):P1.03 (12 March 2000) |
|
Meeting abstract
Breast cancer in young women: prevalence of LOH at SM Johnson, JA Shaw, RA Walker Breast Cancer Res 2000, 2(Suppl 1):P1.04 (12 March 2000) |
|
Meeting abstract
I Konstantopoulou, C Croupis, A Ladopoulou, A Pantazidis, E Lianidou, K Venetsanou, E Efstathiou, M Petersen, J Janinis, G Fountzilas, E Chiotellis, D Yannoukakos Breast Cancer Res 2000, 2(Suppl 1):P1.05 (12 March 2000) |
|
Meeting abstract
Germline K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna, R Winqvist Breast Cancer Res 2000, 2(Suppl 1):P1.09 (12 March 2000) |
|
Meeting abstract
Germline B Csokay, N Udvarhelyi, E Olah Breast Cancer Res 2000, 2(Suppl 1):P1.12 (12 March 2000) |
|
Meeting abstract
Constitutional alterations of 9p23-24 in independent M Schwab, L Savelyeva, A Claas, H An, S Brouwers Breast Cancer Res 2000, 2(Suppl 1):P1.13 (12 March 2000) |
|
Meeting abstract
kConFab: a unique Australasian research initiative for familial breast cancer J Sambrook Breast Cancer Res 2000, 2(Suppl 1):P1.14 (12 March 2000) |
|
Meeting abstract
C Ghimenti, E Sensi, D Iandolo, G Cipollini, S Ricci, PF Conte, G Bevilacqua, MA Caligo Breast Cancer Res 2000, 2(Suppl 1):P1.15 (12 March 2000) |
|
Meeting abstract
Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions P Mote, C Clarke Breast Cancer Res 2000, 2(Suppl 1):P2.01 (12 March 2000) |
|
Meeting abstract
CA Lange, T Shen, KB Horwitz Breast Cancer Res 2000, 2(Suppl 1):P2.06 (12 March 2000) |
|
Meeting abstract
The expression of the EGFR family members in breast carcinomas Z Suo, JM Nesland Breast Cancer Res 2000, 2(Suppl 1):P3.01 (12 March 2000) |
|
Meeting abstract
Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer O Stal, L Akerberg, B Nordenskjold, B Olsson, LE Rutqvist, L Skoog Breast Cancer Res 2000, 2(Suppl 1):P3.04 (12 March 2000) |
|
Meeting abstract
J Giannos, P Ginopulos Breast Cancer Res 2000, 2(Suppl 1):P3.05 (12 March 2000) |
|
Meeting abstract
G Westman Breast Cancer Res 2000, 2(Suppl 1):P3.08 (12 March 2000) |
|
Meeting abstract
Heterogeneity in the clinical phenotype of J Alsner, M Yilmaz, P Guldberg, LL Hansen, J Overgaard Breast Cancer Res 2000, 2(Suppl 1):P4.04 (12 March 2000) |
|
Meeting abstract
Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients A Langerød, TI Andersen, I Bukholm, A-L Børresen Dale Breast Cancer Res 2000, 2(Suppl 1):P4.06 (12 March 2000) |
|
Meeting abstract
E Sensi, C Ghimenti, G Cipollini, D Iandolo, G Naccarato, P Viacava, G Bevilacqua, MA Caligo Breast Cancer Res 2000, 2(Suppl 1):P4.07 (12 March 2000) |
|
Meeting abstract
Constitutional alterations of the P Maillet, H Bonnefoi, A-P Sappino Breast Cancer Res 2000, 2(Suppl 1):P4.09 (12 March 2000) |
|
Meeting abstract
Modulation of GV Vutskits, P Salmon, JV Soriano, C Cudre-Mauroux, D Trono, R Montesano, A-P Sappino Breast Cancer Res 2000, 2(Suppl 1):P4.10 (12 March 2000) |
|
Meeting abstract
A-M Cleton-Jansen, HM van Beerendonk, NT ter Haar, PHC Eilers, HC van Houwelingen, BA Bonsing, VTHBM Smit, G-JB van Ommen, CJ Cornelisse Breast Cancer Res 2000, 2(Suppl 1):P4.11 (12 March 2000) |
|
Meeting abstract
Analysis of chromosome alterations and the S Ingvarsson, C Huiping, JG Jonasson, BA Agnarsson Breast Cancer Res 2000, 2(Suppl 1):P4.13 (12 March 2000) |
|
Meeting abstract
Excluding TTC4 as a target for loss on chromosome 1p31 in human breast cancer Y Hey, W Brintnell, L James, J Varley Breast Cancer Res 2000, 2(Suppl 1):P4.14 (12 March 2000) |
|
Meeting abstract
Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells R Zeillinger, B Schmid, D Tong, B Fasching, I Schiebl, M Stimpfl, A Obermair, S Leodolter Breast Cancer Res 2000, 2(Suppl 1):P4.16 (12 March 2000) |
|
Meeting abstract
R Lilischkis, H Kneitz, H Kreipe Breast Cancer Res 2000, 2(Suppl 1):P5.02 (12 March 2000) |
|
Meeting abstract
Estrogen-dependent c-jun upregulation may control cyclin D1 expression MD Planas-Silva, J Liu Donaher, RA Weinberg Breast Cancer Res 2000, 2(Suppl 1):P5.03 (12 March 2000) |
|
Meeting abstract
L Elmore, A Akalin, L Gollahon, G Clarke, M Grimes, RT Burks, A Ferreira-Gonzalez, C Garrett, S Holt Breast Cancer Res 2000, 2(Suppl 1):P6.02 (12 March 2000) |
|
Meeting abstract
J DiRenzo, R Rivera-Gonzalez, M Brown Breast Cancer Res 2000, 2(Suppl 1):P6.03 (12 March 2000) |
|
Meeting abstract
Molecular analyses of human breast cancer metastasis: genetic markers of progression K Driouch, R Lidereau Breast Cancer Res 2000, 2(Suppl 1):P7.01 (12 March 2000) |
|
Meeting abstract
S Lafarge, M Ferrara, YJ Bignon Breast Cancer Res 2000, 2(Suppl 1):P7.04 (12 March 2000) |
|
Meeting abstract
Genetic alterations in ductal carcinoma E Robanus-Maandag, C Bosch, C Vos, H Peterse, M van de Vijver Breast Cancer Res 2000, 2(Suppl 1):P8.07 (12 March 2000) |
|
Meeting abstract
Identification of two novel breast cancer associated genes by the differential display method N Maass, K Nagasaki, VR Jacobs, W Jonat Breast Cancer Res 2000, 2(Suppl 1):P8.08 (12 March 2000) |
|
Meeting abstract
Expression profiling of EMJJ Berns, IL van Staveren, L Verhoog, JA Foekens, JGM Klijn Breast Cancer Res 2000, 2(Suppl 1):P8.09 (12 March 2000) |
|
Oral presentation
The importance of breast cancer research from a patient's view: the voices and visions of advocates S Leigh Breast Cancer Res 2000, 2(Suppl 1):S.01 (12 March 2000) |
|
Oral presentation
Genetic testing for BL Weber Breast Cancer Res 2000, 2(Suppl 1):S.04 (12 March 2000) |
|
Oral presentation
The pathology of inherited breast tumours M Stratton Breast Cancer Res 2000, 2(Suppl 1):S.05 (12 March 2000) |
|
Oral presentation
Other cancers in B Ponder Breast Cancer Res 2000, 2(Suppl 1):S.07 (12 March 2000) |
|
Oral presentation
The role of coactivators in oestrogen action M Brown, JF de Mora Breast Cancer Res 2000, 2(Suppl 1):S.08 (12 March 2000) |
|
Oral presentation
Growth regulation and steroid hormone resistance in breast cancer KB Horwitz Breast Cancer Res 2000, 2(Suppl 1):S.09 (12 March 2000) |
|
Oral presentation
Clinical translation of progress in molecular endocrinology M Dowsett Breast Cancer Res 2000, 2(Suppl 1):S.12 (12 March 2000) |
|
Oral presentation
DJ Slamon Breast Cancer Res 2000, 2(Suppl 1):S.14 (12 March 2000) |
|
Oral presentation
Characterisation of micrometastatic tumor cells K Pantel Breast Cancer Res 2000, 2(Suppl 1):S.16 (12 March 2000) |
|
Oral presentation
Animal models of human tumor suppressor genes TW Mak Breast Cancer Res 2000, 2(Suppl 1):S.17 (12 March 2000) |
|
Oral presentation
Drug discovery in the p53 pathway DP Lane, C Midgley, A Sparks, C Blattner, C Binden, S Laine Breast Cancer Res 2000, 2(Suppl 1):S.18 (12 March 2000) |
|
Oral presentation
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, GR Cunha, P Hein, TD Tlsty Breast Cancer Res 2000, 2(Suppl 1):S.19 (12 March 2000) |
|
Oral presentation
p53-mediated apoptosis and genomic instability syndromes EA Spillare, XW Wang, SP Linke, A Robles, CC Harris Breast Cancer Res 2000, 2(Suppl 1):S.20 (12 March 2000) |
|
Oral presentation
Lessons from P Hainaut, M Olivier Breast Cancer Res 2000, 2(Suppl 1):S.21 (12 March 2000) |
|
Oral presentation
p53 action in apoptosis and senescence SW Lowe, CA Schmitt, G Ferbeyre, AW Lin, E de Stanchina, M Soengas Breast Cancer Res 2000, 2(Suppl 1):S.22 (12 March 2000) |
|
Oral presentation
Cancer susceptibility in RA Gatti, P Concannon Breast Cancer Res 2000, 2(Suppl 1):S.23 (12 March 2000) |
|
Meeting abstract
O Díez, C Pericay, M Domènech, J Brunet, J Cortés, J Balmaña, A Gómez, JJ López, MC Alonso, M Baiget Breast Cancer Res 2000, 2(Suppl 1):P1.02 (12 March 2000) |
|
Meeting abstract
Z Kote-Jarai, TP Powles, S Ashley, DF Easton, L Assersohn, N Sodha, M Dowsett, B Gusterson, A Tidy, G Mitchell, RA Eeles Breast Cancer Res 2000, 2(Suppl 1):P1.06 (12 March 2000) |
|
Meeting abstract
Mutational analysis of JI Martínez-Ferrandis, A Vega, P Marín-Garcia, F Barros, FJ Chaves, A Carracedo, ME Armengod, I Chirivella, A Lluch, J García-Conde, A Cervantes Breast Cancer Res 2000, 2(Suppl 1):P1.07 (12 March 2000) |
|
Meeting abstract
One test to identify 50% of all Norwegian P Møller, E Hovig, K Lycke, RAP Stacy, OJ Dahlberg, A Hagen, B Hagen, K Løvslett, H Qvist, K Heimdal Breast Cancer Res 2000, 2(Suppl 1):P1.08 (12 March 2000) |
|
Meeting abstract
X chromosome inactivation pattern in female patients with breast cancer M Kristiansen, A Langer, GP Knudsen, BL Weber, A-L Børresen-Dale, KH Ørstavik Breast Cancer Res 2000, 2(Suppl 1):P1.10 (12 March 2000) |
|
Meeting abstract
A Vega, JI Martínez, F Barros, P Marín-García, FJ Chavez, C Ruiz-Ponte, I Chirivella, A Lluch, A Cervantes, I García-Conde, ME Armengod, A Carracedo Breast Cancer Res 2000, 2(Suppl 1):P1.11 (12 March 2000) |
|
Meeting abstract
Mammary-specific targeting of the murine NK Collins, KA McAllister, LM Bennett, K-U Wagner, T Ward, J Malphurs, G Goulding, EM Eddy, BJ Davis, RW Wiseman Breast Cancer Res 2000, 2(Suppl 1):P1.16 (12 March 2000) |
|
Meeting abstract
BK Lundholt, P Briand, AE Lykkesfeldt Breast Cancer Res 2000, 2(Suppl 1):P2.02 (12 March 2000) |
|
Meeting abstract
A Ström, N Arai, J Leers, J-Å Gustafsson Breast Cancer Res 2000, 2(Suppl 1):P2.03 (12 March 2000) |
|
Meeting abstract
Genetic variants of V Nedelcheva Kristensen, N Harada, N Yoshimura, E Haraldsen, PE Lønning, B Erikstein, R Kåresen, T Kristensen, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P2.04 (12 March 2000) |
|
Meeting abstract
L-A Martin, CMW Chan, C Marshall, M Dowsett Breast Cancer Res 2000, 2(Suppl 1):P2.05 (12 March 2000) |
|
Meeting abstract
H Östlund, A Burger, A Seth, G Landberg Breast Cancer Res 2000, 2(Suppl 1):P3.02 (12 March 2000) |
|
Meeting abstract
SS Larsen, AE Lykkesfeldt Breast Cancer Res 2000, 2(Suppl 1):P3.03 (12 March 2000) |
|
Meeting abstract
Factors modulating integrin Beta I expression on the breast cancer cell lines MCF-7 and MDA-MB-231 CJ Pogson, CMW Chan, L-A Martin, GPH Gui, M Dowsett Breast Cancer Res 2000, 2(Suppl 1):P3.06 (12 March 2000) |
|
Meeting abstract
TI Andersen, E Skovlund, IK Bukholm, U Jacobsen, R Kåresen, B Erikstein, J Nesland, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P3.07 (12 March 2000) |
|
Meeting abstract
Role of the breast cancer susceptibility gene V Sylvain, Y-J Bignon Breast Cancer Res 2000, 2(Suppl 1):P4.01 (12 March 2000) |
|
Meeting abstract
H Vidarsson, E Mikaelsdottir, JE Eyfjörd, H Ögmundsdóttir, T Rafnar, S Valgeirsdóttir Breast Cancer Res 2000, 2(Suppl 1):P4.02 (12 March 2000) |
|
Meeting abstract
Embryonic lethality in the P Hohenstein, M Kielman, C Breukel, P Krimpenfort, A Berns, M Bennett, R Wiseman, C Cornelisse, G-J van Ommen, P Devilee, R Fodde Breast Cancer Res 2000, 2(Suppl 1):P4.03 (12 March 2000) |
|
Meeting abstract
The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours K Gudmundsdóttir, L Tryggvadóttir, JE Eyfjörd Breast Cancer Res 2000, 2(Suppl 1):P4.05 (12 March 2000) |
|
Meeting abstract
Screening breast cancer patients for Norwegian K Laake, P Vu, TI Andersen, B Erikstein, R Kåresen, PE Lønning, E Skovlund, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P4.08 (12 March 2000) |
|
Meeting abstract
Analysis of Fhit expression in stages of breast cancer progression M Campiglio, G Somenzi, P Aiello, F Wärnberg, L Holmberg, CM Croce, S Menard Breast Cancer Res 2000, 2(Suppl 1):P4.12 (12 March 2000) |
|
Meeting abstract
A detailed physical map of a region within human chromosome 16q22.1 E Frengen, P Rocca-Serra, S Shaposhnikov, L Taine, J Thorsen, C Bépoldin, M Longy, H Prydz, F Dorion-Bonnet Breast Cancer Res 2000, 2(Suppl 1):P4.15 (12 March 2000) |
|
Meeting abstract
S Geisler, B Smith-Sørensen, D Betticher, IK Bukholm, LA Akslen, A Kappeler, M Gugger, PE Lønning, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P5.01 (12 March 2000) |
|
Meeting abstract
M Schreiber, F Piu, A Kolbus, A Szabowski, U Möhle-Steinlein, J Tian, M Karin, P Angel, EF Wagner Breast Cancer Res 2000, 2(Suppl 1):P5.04 (12 March 2000) |
|
Meeting abstract
Setting up an efficient and reliable screening method for novel c-Jun N-terminal kinase substrates T Kallunki, C Holmberg, M Lerdrup-Hansen, T Herdegen, A Aronheim, M Jäättelä Breast Cancer Res 2000, 2(Suppl 1):P5.05 (12 March 2000) |
|
Meeting abstract
Angiogenesis in breast cancer: establishing a link between angiogenesis and hormone regulation R Soares, C Costa, F Gärtner, F Schmitt Breast Cancer Res 2000, 2(Suppl 1):P6.01 (12 March 2000) |
|
Meeting abstract
AKT-1 and BCL-2 co-expression in breast cancer patients correlates with better survival G Pérez-Tenorio, O Stål Breast Cancer Res 2000, 2(Suppl 1):P7.02 (12 March 2000) |
|
Meeting abstract
Does a polymorphism in the G Ursin, SA Ingles, H Spencer Feigelson, GA Coetzee, L Bernstein, MC Pike, A Buley Breast Cancer Res 2000, 2(Suppl 1):P7.03 (12 March 2000) |
|
Meeting abstract
Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer PF Ferrucci, C Rabascio, C Corsini, F Tealdo, M Paolucci, F Bertolini, H El Taani, G Martinelli Breast Cancer Res 2000, 2(Suppl 1):P7.05 (12 March 2000) |
|
Meeting abstract
Promising method for DNA extraction from paraffin embedded archive material A Bregård, P Vu, G Geitvik, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P8.01 (12 March 2000) |
|
Meeting abstract
F Boeckman, L Tan, K Hamby Breast Cancer Res 2000, 2(Suppl 1):P8.02 (12 March 2000) |
|
Meeting abstract
U Lehmann, S Glöckner, W Kleeberger, R von Wasielewski, H Kreipe Breast Cancer Res 2000, 2(Suppl 1):P8.03 (12 March 2000) |
|
Meeting abstract
Screening for P Kringen, HG Eiken, JC Pedersen, S Egedal, K Berg, KM Tveit, TI Andersen Breast Cancer Res 2000, 2(Suppl 1):P8.04 (12 March 2000) |
|
Meeting abstract
Hypervariable area in the 5' flanking region of V Nedelcheva Kristensen, T Kristensen, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P8.05 (12 March 2000) |
|
Meeting abstract
Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast C Jones, MP Foschini, R Chaggar, Y-J Lu, D Wells, JM Shipley, V Eusebi, SR Lakhani Breast Cancer Res 2000, 2(Suppl 1):P8.06 (12 March 2000) |
|
Meeting abstract
Transcript profiles and genotyping of cancer tissue C Malmqvist, M Sievertzon, A Gustafsson, A Holmberg, M Larsson, A Alderborn, M Uhlén, J Lundeberg Breast Cancer Res 2000, 2(Suppl 1):P8.10 (12 March 2000) |
|
Meeting abstract
Relation of gene expression-based tumor subclasses to clinical phenotypes T Sørlie, CM Perou, PE Lønning, PO Brown, D Botstein, A-L Børresen-Dale Breast Cancer Res 2000, 2(Suppl 1):P8.11 (12 March 2000) |
|
Oral presentation
Molecular characteristics of inherited breast tumors Å Borg, IA Hedenfalk, J Vallon-Christersson, N Loman, O Johannsson, H Olsson, DJ Duggan, Y Chen, M Bittner, O-P Kallioniemi, JM Trent Breast Cancer Res 2000, 2(Suppl 1):S.06 (12 March 2000) |
|
Oral presentation
Estrogen receptors α and β in the rodent mammary gland S Saji, EV Jensen, S Nilsson, T Rylander, M Warner, J-Å Gustafsson Breast Cancer Res 2000, 2(Suppl 1):S.11 (12 March 2000) |
|
Oral presentation
The EGF receptor family as targets for breast cancer therapy J Baselga Breast Cancer Res 2000, 2(Suppl 1):S.13 (12 March 2000) |
|
Oral presentation
Herceptin in clinical use - early 2000 CL Vogel Breast Cancer Res 2000, 2(Suppl 1):S.15 (12 March 2000) |
|
Oral presentation
Role of the J Hall, S Angèle, M Vuillaume, J-P Gérard, P Romestaing Breast Cancer Res 2000, 2(Suppl 1):S.24 (12 March 2000) |
|
Oral presentation
Tumour-selective transcriptional targeting for breast cancer gene therapy HC Hurst Breast Cancer Res 2000, 2(Suppl 1):S.25 (12 March 2000) |
|
Oral presentation
G1/S control and its deregulation in cancer J Bartek, C Lukas, C Sørensen, E Santoni-Rugiu, J Bartkova, J Lukas Breast Cancer Res 2000, 2(Suppl 1):S.26 (12 March 2000) |
|
Oral presentation
Molecular control of apoptosis in the breast C Streuli, A Gilmore, A Metcalfe, Y-J Lee, J Oliver, A Valentijn Breast Cancer Res 2000, 2(Suppl 1):S.27 (12 March 2000) |
|
Speaker presentations
Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy AL Harris Breast Cancer Res 2000, 2(Suppl 1):S.28 (12 March 2000) |
|
Oral presentation
Telomerase: a breast cancer chemopreventive and therapeutic target JW Shay Breast Cancer Res 2000, 2(Suppl 1):S.29 (12 March 2000) |
|
Oral presentation
Blood assays for earlier detection of cancers AB Pardee, RJ Guan, HL Ford, MV Fournier, K Martin, R Sager Breast Cancer Res 2000, 2(Suppl 1):S.30 (12 March 2000) |
|
Oral presentation
Predictive factors in breast cancer J Klijn, E Berns, L Dorssers, J Foekens Breast Cancer Res 2000, 2(Suppl 1):S.32 (12 March 2000) |
|
Oral presentation
Clinical trials in breast cancer; do we have the right approaches? PE Lønning Breast Cancer Res 2000, 2(Suppl 1):S.33 (12 March 2000) |
|
Oral presentation
Tissue microarrays for high-throughput profiling in molecular oncology O-P Kallioniemi, J Kononen, G Sauter Breast Cancer Res 2000, 2(Suppl 1):S.34 (12 March 2000) |
|
Oral presentation
Two molecular cytogenetic views of breast cancer J Gray, K Chin, C Collins, P Yaswin, G Nonet, D Kowbel, W-L Kuo, E Garcia, C Ortiz de Solorzano, D Knowles, S Lockett, M Bissell, V Weaver, D Pinkel, D Albertson, A-L Børresen-Dale, F Waldnian Breast Cancer Res 2000, 2(Suppl 1):S.35 (12 March 2000) |
|
Oral presentation
Studying breast cancer on a genomic scale using DNA microarrays D Botstein, PO Brown Breast Cancer Res 2000, 2(Suppl 1):S.36 (12 March 2000) |
